New York · Nonprofit
GLOBAL HIV VACCINE ENTERPRISE
GLOBAL HIV VACCINE ENTERPRISE (New York) receives grants from 1 organization whose IRS filings report $1,399,999 to it, the largest being GATES FOUNDATION ($1,399,999). 0 of them have funded it in more than one year.
- Revenue FY2017
- $1.2M
- Funders on record
- 1
- Grants received
- $1.4M
- Net assets
- $1.3M
What Global HIV Vaccine Enterprise does
Mission
The Global HIV Vaccine Enterprise (the enterprise) is an alliance of independent organizations dedicated to accelerating the development of safe and effective hiv vaccines for use globally. It moves vaccine research and development forward among organizations through coordination, collaboration, knowledge-sharing and efforts to attract interest, resources and funders to the field. Since 2014, the enterprise has hosted the successful, new, biennial hiv research for prevention (hivr4p) conference. Hivr4p, the worlds only scientific meeting dedicated exclusively to biomedical hiv prevention research, brings together policy experts, funders, stakeholders and others to share and discuss the latest scientific developments from all hiv prevention disciplines and approaches, including their distinctive features, commonalities and combination.
As stated on its FY2017 Form 990.
Program
Meetings/program - a) strategic convening/timely topics in hiv vaccines series: the search for a safe and effective hiv vaccine has progressed further and faster in the last few years than at any time since the epidemic began. This progress poses new questions, new opportunities and new challenges as to what and how the hiv vaccine research endeavor should move forward. To help identify and respond to unresolved and emerging priority issues and move hiv vaccine r&d forward, the enterprise produces its timely topics in hiv vaccines series. Through an open call for proposals, the enterprise identifies the most strategic needs of the field and sponsors think tanks, meetings, forums and other events in addition to developing useful tools to tackle these issues. Issues addressed to date include vaccine-induced sero-positivity/ sero-reactivity, a mucosal guide, and antibody durability, among others. B) to strengthen recognition of the enterprise mission, programs, stakeholder goals and achievements, as well as keep current on the state of hiv vaccine research, the enterprise secretariat participated in various scientific and advisory meetings and discussions with partners and…
The first program described on its most recent Form 990, which lists programs largest first by expense.
Who funds it, year by year
Grant support over time, funder by funder — shade shows the grant size each year.
From the IRS filings of GLOBAL HIV VACCINE ENTERPRISE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
GLOBAL HIV VACCINE ENTERPRISE draws 100% of its grant income from funders outside New York, across 1 state in all.
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like GLOBAL HIV VACCINE ENTERPRISE
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
58% of spending goes to programs.
Governance
Public support
55%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 3 states
Screen this organization
A dated, signed PDF of the compliance screen for GLOBAL HIV VACCINE ENTERPRISE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds GLOBAL HIV VACCINE ENTERPRISE?
- GLOBAL HIV VACCINE ENTERPRISE (New York) receives grants from 1 organization whose IRS filings report $1,399,999 to it, the largest being GATES FOUNDATION ($1,399,999). 0 of them have funded it in more than one year.
- How many funders does GLOBAL HIV VACCINE ENTERPRISE have?
- IRS filings report 1 organization giving $1,399,999 in grants to GLOBAL HIV VACCINE ENTERPRISE.
- Who is the largest funder of GLOBAL HIV VACCINE ENTERPRISE?
- GATES FOUNDATION is the largest funder on record, with $1,399,999 in grants. The full list of funders is on this page.
- How can an organization like GLOBAL HIV VACCINE ENTERPRISE find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Global HIV Vaccine Enterprise →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2017 (financials across 2017–2017), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing